| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.072 | 0.06 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.06 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.06 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.06 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.068 | 0.06 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.097 | 0.06 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.06 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | -0.29 | 0.06 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.06 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.06 |